Statin effektivt mot hjärtsjukdom

Lakartidningen

Volumn 93, Issue 22, 1996, Pages 2131-2133

  Olsson, Anders G ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HUMAN; MALE; MIDDLE AGED; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SCANDINAVIA; UNITED KINGDOM;

ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; CORONARY DISEASE; HUMANS; LOVASTATIN; MALE; MIDDLE AGED; PRAVASTATIN; SCANDINAVIA; SCOTLAND; SIMVASTATIN;

EID: 0030605625     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Shepherd J, Cobbe S, Ford I, Isles CG, Lorimer AR, Macfarlane PW et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-7.
2. Committee of Principal Investigators. A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate. Br Heart J 1978; 40: 1069-1118.
3. Lipid Research Clinics Program. The Lipid Research Clinics coronary primary prevention trial results. JAMA 1984; 251: 351-74.
4. Frick M, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P et al. The Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987; 317: 1237-45.
5. West of Scotland Coronary Prevention Study Group. A coronary primary prevention study of Scottish men aged 45-64 years: trial design. J Clin Epidemiol 1992; 45: 849-60.
6. The Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
7. Behandling av hyperlipidemi. Information från Läkemedelsverket 1995; 3: 178-87.
8. Hellström K. Var står vi i lipidfrågan? Läkartidningen 1995; 92: 4317-8.
9. Haq I, Jackson P, Yeo W, Ramsay L. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet 1995; 346: 1467-71.
10. Pyörälä K, Backer GD, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300-31.
11. Oliver M. Statins prevent coronary heart disease. Lancet 1995; 346: 1378-9.